Drake KW, Adam RD.  Neurology 2009; 73:1780-1786
 Most patients present with headache only (77%) while 23 % had nuchal  rigidity, 39 % had mental status changes,  and one third focal signs  especially gait disturbance or ataxia, may be due to hydrocephalus.    Risk factors are HIV/chronic steroids but not diabetes.  Also, liver  failure, hem/lymph malignancies, and ESRD.  Increased risk for males (2:1),  Hispanic, black and Asian patients in endemic areas (black patients have 6:1  risk).  CSF had mononuclear pleocytosis, 69 % had abnormally low glucose,  occasionally high protein or eosinophils.  CSF antibody/culture often  negative on presentation (50 %), but in those patients, serum antibody test is  usually positive. Also CSF cultures or brain biopsy occasionally used for  diagnosis.   Imaging may show basilar meningitis or hydrocephalus and  vasculitic infarcts.  Many patients had antecedent illnesses, including  respiratory, that may or may not have been diagnosed as coccidio  or  occasionally  osteomyelitis, lymphadenitis, skin lesions, and soft tissue  masses.  Treatment is with azoles, esp. fluconazole which has supplanted  amphotericin and others.  Relapse can occur years or even decades later if  azole therapy is stopped.  Shunts are frequently needed for treatment of  hydrocephalus.  Prognosis is now good for those compliant with  therapy.
 
 
 
 
 Posts
Posts
 
 
 
No comments:
Post a Comment